Potential for herb-drug interactions associated with furanocoumarin compounds, the major bioactive c

来源 :2015年第一届药代动力学朝阳论坛 | 被引量 : 0次 | 上传用户:zdhks008
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Herbal medicinal products belong to a main part of complementary and alternative medicine and have worldwide using integrated with conventional medicines for treatment.However, the increasing risk of herb-drug interaction, especially mediated by metabolisming enzymes and transporters in pharmacokinetic pathways, has raised enthusiasm on discovering the underlying mechanisms.Natural furanocoumarin compounds are the major bioactive components of Radix Angelicae Dahuricae (RAD), a well-known traditional Chinese medicine existing in many herbal formulas such as Fufang Yangjiao Pian and Jiuwei Qianghuo Tang.The present study was conducted to investigate the pharmacokinetics of furanocoumarin compounds from RAD extract and potential herb-drug interaction in association with metabolism enzymes and transporters.The study revealed that imperatorin (IM) and isoimperatorin (ISOIM), two major bioactive components of natural furanocoumarin had high plasma concentrations and were absorbed and eliminated rapidly with high exposure in liver.
其他文献
  Drug metabolism has become an integral part of drug discovery and development from the earliest stage, and this change may have been driven by the evolution
会议
  Diosbulbin B (DIOB) is the most abundant component of Dioscorea bulbifera L.(DB), a traditional Chinese medicine herb.DIOB and DB extracts have been reporte
会议
  The recognition of the gut microbiota-host metabolic axis and its implications in human metabolic disease has highlighted the contribution of the gut microb
会议
  LAT1 overexpressed on membrane of various tumor cells, are potential targets for tumor-targeting therapy.This study aimed to develop a LAT1-mediated drug de
会议
  CPRC1 is a novel investigated proton pump inhibitor, which shows dramaticsuccess in the management of acid-related disorders.Now this drug is being develope
会议
  Prediction of human PK at the preclinical stage can aid: ① human efficacious dose prediction, ②) human safety risk assessment based on detailed pharmacoki
会议
  Trastuzumab Emtansine(T-DM1, KadcylaTM, Genentech Inc.) is an antibody-drug conjugate(ADC) that received US FDA approval in 2013 for the treatment of human
会议
  Fasiglifam (TAK-875), a selective G-protein-coupled receptor 40 agonist, was developed for the treatment of type 2 diabetes mellitus.However, its clinical d
会议
  Many furan-containing compounds have been reported to be toxic and/or carcinogenic.Furanoids occur in a wide range of fruits, herbs, foods, and beverages.Th
会议
  Drug metabolizing enzymes (DMEs) play important roles in mammalians for the synthesis, metabolism and excretion of various kinds of chemicals, including num
会议